Seres Therapeutics, Inc. (MCRB)

15.96 +0.78 (+5.14%) USD  |  NASDAQ  |  Jan 16, 16:00
15.96 0.00 (0.00%) After-Hours: 20:00
More

Seres Therapeutics Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for MCRB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade